Fintel reports that on February 14, 2025, Goldman Sachs upgraded their outlook for Airbnb (NasdaqGS:ABNB) from Sell to ...

More stable investment management and net interest income could cause investors to reassess Goldman's earnings quality and increase their willingness to pay a premium for it.

Mineralys Therapeutics (NASDAQ:MLYS – Get Free Report) had its price objective reduced by research analysts at The Goldman Sachs Group from $28.00 to $24.00 in a research note issued to investors on ...

The investment bank’s first foray into crypto ETFs was in the second quarter of 2024, when it purchased $418 billion worth of ...

Wall Street analysts revised their price targets on Applied Materials, Inc (NASDAQ:AMAT) after the company released its first ...

The Goldman Sachs Group downgraded shares of Banco Bradesco (NYSE:BBD – Free Report) from a buy rating to a sell rating in a research report released on Wednesday, Marketbeat reports. They currently ...

Millennium's $2.6B Bitcoin ETFs and $182M Ethereum ETFs highlight the growing institutional adoption of crypto investments.

Ray Dalio’s Bridgewater Associates, which is one of the world’s largest hedge funds, made significant adjustments to its ...

Moderna is now expecting 2025 research and development costs of about $4.1 billion and selling, general and administrative costs of about $1.1 billion. Cost of sales is expected to come to about $1.2 ...

Barclays (BARC.L) raised its 2025 performance targets this week after reporting a better than expected 24 per cent rise in ...

The Japanese investment holding company SoftBank Group (OTCPK:SFTBY) purchased two new stakes: 20.45M shares in Pacific Biosciences of California (PACB), and 14.66M shares in Recursion Pharmaceuticals ...